吉利德科学升2.3% 公司HIV预防药获CHMP加速审批

金吾资讯
25 Jul

金吾财讯 | 吉利德科学(GILD)股价上扬,截至发稿,涨2.31%,报115.81美元。公司今日宣布,欧洲药品管理局(EMA)下属人用药品委员会(CHMP)已通过加速审评程序出具积极审评意见,推荐该公司HIV-1衣壳抑制剂注射剂lenacapavir用于暴露前预防(PrEP),以降低存在HIV-1感染风险的成年及青少年群体经性行为感染该病毒的概率。最终审批决定预计于今年晚些时间公布,若获批上市,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10